Ido Wolf
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 61
- Cancer Immunotherapy and Biomarkers 16
- Pancreatic and Hepatic Oncology Research 13
- Colorectal Cancer Treatments and Studies 7
-
- Breast Cancer Treatment Studies 13
- Co-authors
- Tamar Rubinek (39 shared papers)Bella Kaufman (13 shared papers)Hagai Ligumsky (10 shared papers)Raphael Catane (9 shared papers)Hannah Kanety (7 shared papers)Harold Phillip Koeffler (7 shared papers)Avraham Karasik (3 shared papers)Beth Y. Karlan (6 shared papers)
- Journals
- The Oncologist (9 papers)Oncogene (9 papers)The Lancet Oncology (7 papers)Breast Cancer Research and Treatment (7 papers)ESMO Open (4 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ido Wolf
149 papers receiving 6.9k citations
Ido Wolf's Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 1.2k
- Oncology 1.9k
- Hepatology 376
- Nephrology 341
- Health Informatics 82
Countries citing papers authored by Ido Wolf
This map shows the geographic impact of Ido Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ido Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ido Wolf more than expected).
Fields of papers citing papers by Ido Wolf
This network shows the impact of papers produced by Ido Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ido Wolf. The network helps show where Ido Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Ido Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer Hit paper breakdown → | 2021 | 589 |
| 2 | Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2014 | 555 |
| 3 | Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility Hit paper breakdown → | 2013 | 442 |
| 4 | 2005 | 356 | |
| 5 | 2013 | 343 | |
| 6 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 7 | 2017 | 284 | |
| 8 | 2008 | 266 | |
| 9 | 2016 | 261 | |
| 10 | 2006 | 182 | |
| 11 | 2006 | 159 | |
| 12 | 2021 | 152 | |
| 13 | 1996 | 124 | |
| 14 | 2011 | 111 | |
| 15 | 2021 | 103 | |
| 16 | 2011 | 101 | |
| 17 | 2021 | 99 | |
| 18 | 2007 | 91 | |
| 19 | 2011 | 91 | |
| 20 | 2006 | 89 |
About Ido Wolf
Ido Wolf is a scholar working on Oncology, Cancer Research, Nephrology, Endocrinology, Diabetes and Metabolism and Genetics, having authored 157 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Pancreatic and Hepatic Oncology Research (13 papers), Breast Cancer Treatment Studies (13 papers), Metabolism, Diabetes, and Cancer (9 papers), Estrogen and related hormone effects (8 papers), Parathyroid Disorders and Treatments (7 papers), Colorectal Cancer Treatments and Studies (7 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.9k citations), Hepatology (376 citations), Nephrology (341 citations) and Health Informatics (82 citations). Ido Wolf has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Tamar Rubinek, Bella Kaufman, Hagai Ligumsky, Raphael Catane, Hannah Kanety, Harold Phillip Koeffler, Avraham Karasik, Beth Y. Karlan, Barliz Waissengrin and Siegal Sadetzki. Their work appears in journals such as The Oncologist, Oncogene, The Lancet Oncology, Breast Cancer Research and Treatment and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.